The Global Whole Exome Sequencing Market is anticipated to upsurge till USD 3,963.14 Million by 2027 with CAGR of over 15% within 2020-2027.
Market Driver:
Exome sequencing is used for accurate disease diagnosis for minimizing the mortality rate. Exome sequencing guides regarding the information related to mutation within the gene leading to tumor progression or suppression. Next generation sequencing is used for diagnosing cancer, a prominent cause of death globally. Increasing prevalence of cancer, which is responsible for death of 6 million people in 2018, is driving demand for effective diagnostic technique. In addition to this, growing prevalence of single gene disorder is acting as driving force for growth of whole exome sequencing.
Whole Genome Sequencing determines complete DNA sequencing escalating the overall cost of the sequencing procedure. However, the exome sequencing code is only for the exon portion, which applies next-generation technology for determination variation of exome. Due to this, it reduces the overall sequencing cost and offers rapid diagnosis in order to detect mutations and indel in the region. Due to relatively low cost of exome sequencing, the market is expected to grow in the years to follow.
Market Restraint:
Whole exome sequencing technique has emerged as novel technique in detection of gene mutations leading to genetic diseases. However, higher dependence on the regulatory authorities such as Food and Drug Administration (FDA) hinders the market growth. The guidelines set by FDA includes certain considerations regarding design, production and validation of the exome sequencing, hampers launch of new products by the potential market players, which in turn hinders the market growth
The report on the whole exome sequencing market covers a deep dive analysis of historic, recent and current market trends. Furthermore, market share/ranking analysis of key players, market dynamics, competition landscape, country-wise analysis for each region covered and the entire supply chain dynamics are covered through the below segmentation.
Report Features |
Specifics |
---|---|
Historical/Estimated/Forecasted Market Size Years |
2018-2027 |
Base Year for Market Calculation |
2019 |
Forecasted Period |
2020-2027 (2020 estimated year, forecasted up to 2027) |
Measured Units |
Value (USD Million) |
Segments Included |
Type and Application |
Regional Coverage |
North America, Asia-Pacific, Europe, Middle East & Africa, South America |
For the scope of the report, In-depth segmentation is offered by Forencis Research
Whole Exome Sequencing Market, by Type
Whole Exome Sequencing Market, by Application
Whole Exome Sequencing Market, by Region
60+ MARKET TABLES AND 30+ FIGURES WILL BE INCLUDED IN THE WHOLE EXOME SEQUENCING MARKET STUDY
Note1: Tentative table of contents, may get updated during the course of research.
Note2: Company financial information is subject to availability in public domain
60+ MARKET TABLES AND 30+ FIGURES WILL BE INCLUDED IN THE STUDY